140 results
Page 2 of 7
6-K
zvydr5n
30 May 23
Current report (foreign)
6:20am
6-K
EX-99.1
fzw4lr0 s65wur0k1
30 May 23
Current report (foreign)
6:19am
6-K
EX-99.1
pt4d0h2b548r
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
ndc v7j182nzkvqqv
30 May 23
Current report (foreign)
6:11am
6-K
1k7 sdo4n
11 May 23
Current report (foreign)
6:07am
6-K
r8fim22fjvm
21 Dec 22
Current report (foreign)
6:01am
6-K
csniax osnq
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
vv081g7nc071
4 Nov 22
Current report (foreign)
6:01am
6-K
hjw 1kf2l14c99as77as
27 Oct 22
Current report (foreign)
6:01am
6-K
5i6rdqozn
4 Oct 22
Current report (foreign)
6:06am
6-K
ems82
4 Aug 22
Current report (foreign)
6:07am
6-K
tct2pwl eg5
28 Jul 22
Current report (foreign)
6:09am
6-K
4r6o9y
11 Jul 22
Current report (foreign)
6:05am
S-8
jlyu3kbphqo8sehx
29 Jun 22
Registration of securities for employees
6:13am
6-K
9et9c8ih 0ejjg
24 Jun 22
Current report (foreign)
6:08am
6-K
e9y p14jua3
31 May 22
Current report (foreign)
6:18am
6-K
EX-99.1
i3yjf 1cjmyk916mg4
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
e3ahapvf mf
31 May 22
Current report (foreign)
12:00am
6-K
r7qu8vvo4ohh
11 May 22
Current report (foreign)
6:06am